[EN] ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY<br/>[FR] DÉRIVÉS D'ISOTHIAZOLE-PYRIDINE EN TANT QUE MODULATEURS DE L'ACTIVITÉ DU HIF (FACTEUR INDUCTIBLE PAR L'HYPOXIE)
申请人:FIBROGEN INC
公开号:WO2009089547A1
公开(公告)日:2009-07-16
The present invention relates to novel compounds according to Formula I or II, methods, and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF). Formula (I) or (II).
Nitrile sulphide formation from the thermal fragmentation of 1,3,4-oxathiazoles: a retro-1,3-dipolar cycloaddition
作者:R. Michael Paton、Fiona M. Robertson、John F. Ross、John Crosby
DOI:10.1039/c39800000714
日期:——
1,3,4-Oxathiazoles, on thermolysis, undergo retro-1,3-dipolar cycloaddition to afford carbonyl compounds and nitrilesulphides, which may be trapped by cycloaddition with alkynes and nitriles.
Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity
申请人:Zhou Xiaoti
公开号:US08952160B2
公开(公告)日:2015-02-10
The present invention relates to novel compounds according to Formula I or II, methods, and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF). Formula (I) or (II).
ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY
申请人:FibroGen, Inc.
公开号:US20150209336A1
公开(公告)日:2015-07-30
The present invention relates to novel compounds according to Formula I or II, methods, and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF). Formula (I) or (II).
ISOTHIAZOLE-PYRIDINE DERIVATES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY
申请人:Zhou Xiaoti
公开号:US20100330199A1
公开(公告)日:2010-12-30
The present invention relates to novel compounds according to Formula I or II, methods, and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF). Formula (I) or (II).